title: Bleomycin plasma spill-over levels in paediatric patients undergoing intralesional injection for the treatment of haemangiomas.
authors.forename: G
authors.initials: G
authors.lastname: Ionescu
authors.forename: P
authors.initials: P
authors.lastname: Mabeta
authors.forename: N
authors.initials: N
authors.lastname: Dippenaar
authors.forename: T
authors.initials: T
authors.lastname: Muir
authors.forename: P
authors.initials: P
authors.lastname: Fourie
authors.forename: G
authors.initials: G
authors.lastname: Shelver
mesh_terms: D000367:Age Factors; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006391:Hemangioma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007223:Infant; D008297:Male; D011446:Prospective Studies
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin